Annual report pursuant to Section 13 and 15(d)

Schedule I - Condensed Statements of Cash Flow (Details)

v3.22.0.1
Schedule I - Condensed Statements of Cash Flow (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Sale and Leaseback Transaction, Gain (Loss), Net $ 59,427 $ 30,639 $ (47,162)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Deferred income taxes 4,848 (4,747) 4,299
Depreciation and amortization 97,194 74,396 62,404
Foreign currency (gain) loss (1,320) 6,754 10,158
Share-based compensation 5,804 1,891 516
Fair value adjustment of financial assets and liabilities 3,821 (1,014) 0
Other operating activities, net 677 115 0
Changes in assets and liabilities:      
Decrease (increase) in other current assets (5,421) (7,864) 7,212
Increase in other current liabilities 7,867 46,303 5,064
Net cash provided by operating activities 159,191 173,842 43,297
Cash flows from investing activities:      
Net cash used in investing activities (171,777) (407,551) (73,040)
Cash flows from financing activities:      
Receipt of long term debt, net 484,089 570,207 50,934
Issuance of shares in Merger Transaction 0 57,997 0
Payment of Merger Transaction issuance costs (4,773) 0 0
Issuance of redeemable preferred stock, net 0 96,880 0
Dividends paid on redeemable preferred stock (5,892) 0 0
Buyback of long-term debt 0 (1,995) 0
Proceeds from issuance of rights, net 0 11,332 0
Net cash provided by financing activities (26,384) 491,048 31,693
Net increase in cash and cash equivalents and restricted cash (38,970) 257,339 1,950
Effect of exchange rate on cash and cash equivalents and restricted cash 1,464 2,875 1,263
Cash and cash equivalents and restricted cash, beginning of year 312,977 52,763 49,550
Cash and cash equivalents and restricted cash, end of year 272,543 312,977 52,763
Reconciliation of cash and cash equivalents and restricted cash      
Cash and cash equivalents, beginning of year 293,666 32,117 29,891
Restricted cash with respect to bonds, beginning of year 2,782 6,223 5,910
Cash and cash equivalents and restricted cash, beginning of year 312,977 52,763 49,550
Cash and cash equivalents, end of year 252,141 293,666 32,117
Restricted cash with respect to bonds, end of year 0 2,782 6,223
Cash and cash equivalents and restricted cash, end of year 272,543 312,977 52,763
Supplementary cash flow information:      
Cash received for interest 428 1,323 1,809
Cash paid for interest 51,495 40,026 30,622
Cash paid for taxes 14,912 1,163 2,784
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 8,210 7,224 2,941
Purchase of property and equipment under leases 23,730 29,625 16,893
Parent Company      
Cash flows from operating activities:      
Sale and Leaseback Transaction, Gain (Loss), Net 59,198 13,710 (43,539)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Equity (income) loss from subsidiaries (71,955) (23,863) 41,818
Deferred income taxes 519 (130) 0
Amortization debt discount and premium 152 (331) (409)
Depreciation and amortization 0 8 11
Foreign currency (gain) loss (4,656) 4,703 1,645
Share-based compensation 868 1,891 516
Fair value adjustment of financial assets and liabilities 5,021 107 0
Other operating activities, net 0 (38) 0
Changes in assets and liabilities:      
Decrease (increase) in other current assets (1,586) 942 (15)
Increase in other current liabilities (3,713) 490 707
Net cash provided by operating activities 8,726 (2,511) (650)
Cash flows from investing activities:      
Loans to investees (450,000) (68,939) (174)
Repayments of loans to subsidiaries and other investees 0 109,946 14,133
Investment in subsidiary 0 (107,299) 0
Other 0 0 (3)
Net cash used in investing activities (450,000) (66,292) 13,956
Cash flows from financing activities:      
Receipt of long term debt, net 442,737 0 0
Issuance of shares in Merger Transaction 0 60,318 0
Payment of Merger Transaction issuance costs 4,773 0 0
Issuance of redeemable preferred stock, net 0 96,880 0
Dividends paid on redeemable preferred stock 5,892 0 0
Repayment of long-term debt (2,017) (10,953) (10,861)
Buyback of long-term debt 0 (1,995) 0
Proceeds from issuance of rights, net 0 11,332 0
Other 0 (18)
Net cash provided by financing activities 430,055 155,582 (10,879)
Net increase in cash and cash equivalents and restricted cash 28,671 86,779 2,427
Effect of exchange rate on cash and cash equivalents and restricted cash 0 2,875 1,263
Cash and cash equivalents and restricted cash, beginning of year 117,179 27,525 23,835
Cash and cash equivalents and restricted cash, end of year 88,508 117,179 27,525
Reconciliation of cash and cash equivalents and restricted cash      
Cash and cash equivalents, beginning of year 117,179 21,302 17,925
Restricted cash with respect to bonds, beginning of year 0 6,223 5,910
Cash and cash equivalents and restricted cash, beginning of year 117,179 27,525 23,835
Cash and cash equivalents, end of year 88,508 117,179 21,302
Restricted cash with respect to bonds, end of year 0 0 6,223
Cash and cash equivalents and restricted cash, end of year 88,508 117,179 27,525
Supplementary cash flow information:      
Cash received for interest 1,404 2,340 6,714
Cash paid for interest 14 3,840 4,266
Cash paid for taxes 6,175 305 1,123
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 1,765 2,190 0
Issuance of shares 3,000 0 0
Ares Put Option 0 9,201 0
Purchase of property and equipment under leases $ 0 $ 0 $ 49